Log In
Print this Print this

PLK-1 small molecule inhibitor (NMS-1286937, NMS-P937)

  Manage Alerts
Collapse Summary General Information
Company Nerviano Medical Sciences s.r.l.
DescriptionOrally available small molecule polo-like kinase 1 (PLK1) selective inhibitor
Molecular Target Polo-like kinase 1 (PLK1) (STPK13)
Mechanism of ActionPolo-like kinase 1 (PLK1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today